RecruitingNot ApplicableNCT07183657

Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma


Sponsor

Charles University, Czech Republic

Enrollment

1,000 participants

Start Date

Jun 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.


Eligibility

Min Age: 18 Years

Inclusion Criteria11

  • PATIENTS
  • signed informed consent,
  • age ≥ 18 years,
  • previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,
  • ability to cooperate,
  • at least 8 weeks without exacerbation,
  • use of a particular inhaler for at least 3 months.
  • signed informed consent,
  • completed education in medicine, pharmacy, or nursing,
  • more than one year of working experience,
  • care for patients taking inhaled therapy for BA/COPD.

Exclusion Criteria4

  • pre-terminal/terminal stage of any disease,
  • uncooperative patient,
  • significant limitation of mobility or cognitive functions.
  • HEALTHCARE PROFESSIONALS

Interventions

OTHEREducation in inhalation technique

Education in inhalation technique


Locations(1)

University Hospital Hradec Králové

Hradec Králové, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07183657


Related Trials